An 84-year-old man from Haryana has become the first person in India to be administered the Covid drug cocktail on Tuesday.
This into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year.
Mohabbat Singh, was under treatment for the last five days at Gurugram's Medanta Hospital was given the drug over a 30 minute intravenous supply.
The cocktail of two fast acting antibodies-Casirivimab and Imdevimabis seen useful to patients with mild symptoms and provide protection to Covid-19 patients before their condition turn serious and they require hospitalization.
The first batch of the Roche antibody cocktail drug arrived in the country on Monday by Roche India and Cipla Limited.
According to doctor NareshTrehan, Chairman and MD of Medanta hospital: “If these antibodies are injected into a patient infected with the Covid-19 virus at an early stage when the virus is trying to multiply then it blocks the virus from entering the cells of the patient from where it derives nutrition to multiply. So by blocking the virus they are stopping the multiplication of the virus and finally the virus spikes. It is one of the blocking mechanisms that is working against the Covid-19 virus,"
The antibodies are also effective against the new variant B.1.617.2 and this has been verified in laboratories as well but is not recommended for patients who are hospitalized due to severe Covid-19, or those who require oxygen and in patients on chronic oxygen therapy due to underlying non-Covid-19 related comorbidity.